HARROW, INC. — Director's Dealing 2007

Dec 27, 2007

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TRANSDEL PHARMACEUTICALS INC (TDLP)
CIK: 0001360214
Period of Report: 2007-12-27

Reporting Person: Abrams Jeffrey J (Director, 10% Owner)
Reporting Person: Abrams Family Trust (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.001 per share	1562500	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option (Right To Buy)	$2.00	2017-09-16	Common Stock (10000)		Direct

Footnotes

F1: Jeffrey J. Abrams, M.D. is the trustee of the Abrams Family Trust.

F2: These securities are owned solely by Jeffrey J. Abrams, M.D.